NWKLF yields 40.73% · JNJ yields 2.13%● Live data
📍 NWKLF pulled ahead of the other in Year 1
Combined, NWKLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NWKLF + JNJ for your $10,000?
Network International Holdings plc operates as a digital commerce enabler in the Middle East and Africa. The company provides technology-enabled payment solutions to merchants and financial institutions. It offers merchant solutions, which include payment solutions, such as N-Genius payment device, N-Genius mini payment device, and On-the-Go payment device; retail integrated and hospitality solutions; and N-Genius online, buy now pay later, and DPO pay online payment solutions. The company also provides value-added services, including SmartView interactive dashboards, SmartView performance report, dynamic currency conversion, multicurrency online, easy payment plan, 3D secure, and network self-services; and acquiring processing and smart bundle solutions. In addition, it offers card and processing solutions comprising debit and credit card, prepaid card, and commercial card solutions; fraud solutions; loyalty solutions; instant issuance, card control, 3D secure, SmartView, API, and payment plan services; and issuer services. Network International Holdings plc was founded in 1994 and is headquartered in Dubai, the United Arab Emirates.
Full NWKLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.